⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 2024

Sex differences in the global burden of multidrug- resistant tuberculosis without extensive drug resistance in the general population and people living with HIV/AIDS, 1990-2019.

Jin Hyuk Choi Jaeyu Park Young‐Jin Son Semin Kim Richard S. Kwon Hankil Lee Masoud Rahmati Jeonghyun Kang H G Woo A Koyanagi L. A. Smith Guillermo F. López Sánchez Elena Dragioti SH Lee Wonyoung Cho Hyeon Jin Kim Jae Il Shin Dong Keon Yon

View at Publisher

Ask AI

Bookmark

Share

Abstract

Currently, human immunodeficiency virus (HIV) and multi-drug resistant tuberculosis (MDR-TB) without extensive drug resistance (XDR) are significant challenges in terms of the global burden of disease. This study aimed to evaluate the trends of the global burden of MDR-TB without XDR and HIV/AIDS-MDR-TB without XDR, focusing on differences in socioeconomic status and sex for 204 countries and territories across periods from 1990 to 2019.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Choi et al. (2024) studied this question.

synapsesocial.com/papers/68e6c945b6db643587647e18 https://doi.org/10.26355/eurrev_202405_36304

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 20192024 · 84 citations
2Global, regional, and national burden of HIV-negative tuberculosis, 1990–2021: Findings from the Global Burden of Disease 2021 Study2024 · 3 citations
3Global and regional trends in multidrug- or rifampicin-resistant tuberculosis, 2000–2024 with forecasts to 2030: a systematic review and meta-analysisMeta-Analysis · 2026 · 3 citations
4Trends in burden of multidrug-resistant tuberculosis in countries, regions, and worldwide from 1990 to 2017: results from the Global Burden of Disease studyOriginal Research · 2021 · 55 citations
5Global, regional, and national burden of HIV and tuberculosis and predictions by Bayesian age-period-cohort analysis: a systematic analysis for the global burden of disease study 2021Cohort Study · 2024 · 10 citations

More related papers

Epidemiological mapping of drug-susceptible and resistant tuberculosis in 30 WHO high-burden countries: <i>Three decades of GBD 2023 trends, projections to 2043 and concordance with WHO estimates</i>2026
Extensively Drug-resistant Tuberculosis in the World: From 1990 to 2019, by WHO Regions2024
Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990–2021: findings from the Global Burden of Disease Study 20212024